1887

Abstract

The p55 gene of simian immunodeficiency virus macaque strain (SIV) and the core p27 component linked to a synthetic AUG codon have been cloned into adenovirus type 5 vectors to generate either viable E3-replacement or defective E1-replacement viruses. The viruses express the expected SIV proteins in both human and, for the non-defective viruses, monkey cells. A considerable proportion of the p55 produced is exported from the infected cell. These viruses should prove useful both in studies of the immune response to SIV and as components of candidate vaccines aimed specifically at provoking cytotoxic T cell responses.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-74-12-2819
1993-12-01
2022-11-27
Loading full text...

Full text loading...

/deliver/fulltext/jgv/74/12/JV0740122819.html?itemId=/content/journal/jgv/10.1099/0022-1317-74-12-2819&mimeType=html&fmt=ahah

References

  1. Almond N., Page M., Mills K., Jenkins A., Ling C., Thorpe R., Kitchin P. 1990; The production and purification of PCR-derived recombinant simian immunodeficiency virus p27 gag protein; its use in detecting serological and T-cell responses in macaques. Journal of Virological Methods 28:321–326
    [Google Scholar]
  2. Berman P. W., Gregory T. J., Riddle L., Nakamura G. R., Champe M. A., Porter J. P., Wurm F. M., Hershberg R. D., Cobb E. K., Eichberg J. W. 1990; Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gpl20 but not gpl60. Nature, London 345:622–625
    [Google Scholar]
  3. Chanda P. K., Natuk R. J., Mason B. B., Bhat B. M., Greenberg L., Dheer S. K., Molnar-Kimber K. L., Mitzutani S., Lubeck M. D., Davis A. R., Hung P. L. 1990; High level expression of the envelope glycoproteins of human immunodeficiency virus type 1 in presence of rev gene using helper-independent adenovirus type 7 recombinants. Virology 175:536–547
    [Google Scholar]
  4. Cheng S.-M., Lee S.-G., Ronchetti-Blume M., Virk K. P., Mitzutani S., Eichberg J. W., Davis A., Hung P. P., Hirsch V. M., Chanock R. M., Purcell R. H., Johnson P. R. 1992; Coexpression of the simian immunodeficiency virus env and rev proteins by a recombinant human adenovirus host range mutant. Journal of Virology 66:6721–6727
    [Google Scholar]
  5. Cranage M. P., Almond N., Jenkins A., Kitchin P. A. 1989; Transmembrane protein of SIV. Nature, London 342:349
    [Google Scholar]
  6. Desrosiers R. C. 1992; Inching towards a vaccine for AIDS. Current Biology 2:162–163
    [Google Scholar]
  7. Dewar R. L., Natarajan V., Vasudevachari M. B., Salzman N. P. 1990; Synthesis and processing of human immunodeficiency virus type 1 envelope proteins encoded by a recombinant human adenovirus. Journal of Virology 63:129–136
    [Google Scholar]
  8. De Wolf F., Lange J. M. A., Houweling J. T. M., Coutinho R. A., Schellekens P. T., van der Noordaa J., Goudsmit J. 1988; Numbers of CD4+ cells and the levels of core antigen of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men. Journal of Infectious Diseases 158:615–622
    [Google Scholar]
  9. Edmondson W. P., Purcell R. H., Gundelfinger B. F., Love J. W. P., Ludwig W., Chanock R. M. 1966; Immunization by selective infection with type 4 adenovirus grown in human diploid tissue culture. 1. Specific protective effect against epidemic disease. Journal of the American Medical Association 195:453–459
    [Google Scholar]
  10. Gheysen D., Jacobs E., de Foresta F., Thiriart C., Francotte M., Thines D., De Wilde M. 1989; Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected cells. Cell 59:103–112
    [Google Scholar]
  11. Gotch F., Rothbard J., Howland K., Townsend A., McMichael A. 1987; Cytotoxic T lymphocytes recognise a fragment of influenza virus matrix protein in association with HLA-A2. Nature, London 326:881–882
    [Google Scholar]
  12. Graham F. L., Smiley J., Russell W. C., Nairn R. 1977; Characteristics of a human cell line transformed by DNA from human adenovirus type 5. Journal of General Virology 36:59–72
    [Google Scholar]
  13. Haj-Ahmad Y., Graham F. L. 1986; Development of a helper-independent human adenovirus vector and its use in the transfer of the herpes simplex virus thymidine kinase gene. Journal of Virology 57:267–274
    [Google Scholar]
  14. Ho D. D., Kaplan J. C., Rackauskas I. E., Gurney M. E. 1988; Second conserved domain of gpl20 is important for HIV infectivity and antibody neutralization. Science 239:1021–1024
    [Google Scholar]
  15. Ho Y.-S., Galos R., Williams J. 1982; Isolation of type 5 adenovirus mutants with a cold-sensitive host range phenotype: genetic evidence of an adenovirus transformation maintenance function. Virology 122:109–124
    [Google Scholar]
  16. Horwitz M. S. 1990a; Adenoviridae and their replication. In Virology 2nd edn vol 2 pp 1679–1721 Edited by Fields B. N., Knipe D. M. New York: Raven Press;
    [Google Scholar]
  17. Horwitz M. S. 1990b; Adenoviruses. In Virology 2nd edn vol 2 pp 1723–1740 Edited by Fields B. N., Knipe D. M. New York: Raven Press;
    [Google Scholar]
  18. Hu S.-L., Abrams K., Barber G. 1992; Protection of macaques against SIV infection by recombinant subunit immunization approach using SIV envelope glycoprotein gp l60. Science 252:456–459
    [Google Scholar]
  19. Jones N. C., Shenk T. 1978; Isolation of deletion and substitution mutants of adenovirus type 5. Cell 13:181–188
    [Google Scholar]
  20. Jones N. C., Shenk T. 1979; Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell 17:683–689
    [Google Scholar]
  21. Klessig D. F., Grodzicker T. 1979; Mutations that allow human ad2 and ad5 to express late genes in monkey cells map in the viral gene encoding the 72K DNA-binding protein. Cell 17:957–966
    [Google Scholar]
  22. Kruijer W., van Schaik F. M. A., Sussenbach J. S. 1981; Structure and organisation of the gene coding for the DNA binding protein of adenovirus type 5. Nucleic Acids Research 9:4439–4457
    [Google Scholar]
  23. Letvin N. L., Daniel M. D., Sehgal P. K., Desrosiers R. C., Hunt R. D., Waldron L. M., MacKey J. J., Schmidt D. K., Chalifoux L. V., King N. W. 1985; Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 230:71–73
    [Google Scholar]
  24. Logan J., Shenk T. 1984; Adenovirus tripartite leader sequence enhances translation of mRNAs late after infection. Proceedings of the National Academy of Sciences, U.S.A 81:3655–3659
    [Google Scholar]
  25. McAleer W. J., Buynak E. B., Maigetter R. Z., Wampler D. E., Miller W. J., Hilleman M. R. 1984; Human hepatitis B vaccine from recombinant yeast. Nature, London 307:178–180
    [Google Scholar]
  26. McMichael A. J., Michie C. A., Gotch F. M., Smith G. L., Moss B. 1986; Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. Journal of General Virology 67:719–726
    [Google Scholar]
  27. Rusche J. R., Javaherian K., McDanal C., Petro J., Lynn D. L., Grimaila R., Langlois A., Gallo R. C., Arthur L. O., Fischinger P. J., Bolognesi D. P., Putney S. D., Matthews T. J. 1988; Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gpl20. Proceedings of the National Academy of Sciences, U.S.A 85:3198–3202
    [Google Scholar]
  28. Shioda T., Shibuta H. 1990; Production of human immunodeficiency virus (HlV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV. Virology 175:139–148
    [Google Scholar]
  29. Stow N. D. 1981; Cloning of a DNA fragment from the left-hand terminus of the adenovirus type 2 genome and its use in site-directed mutagenesis. Journal of Virology 37:171–180
    [Google Scholar]
  30. Thimmappaya B., Weinberger C., Schneider R. J., Shenk T. 1982; Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection. Cell 31:543–551
    [Google Scholar]
  31. Tollefson A., Scaria A., Saha S. K., Wold W. S. M. 1992; The 11600-Mw protein encoded by region E3 of adenovirus is expressed early but is greatly amplified at late stages of infection. Journal of Virology 66:3633–3642
    [Google Scholar]
  32. Top F. H. Jr, Buescher E. L., Bancroft W. H., Russell P. K. 1971; Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. Journal of Infectious Diseases 124:155–160
    [Google Scholar]
  33. Towbin H., Staehelin T., Gordon J. 1979; Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences, U.S.A. 76:4350–4354
    [Google Scholar]
  34. Valenzuela P., Medina A., Rutter W. J., Ammerer G., Hall B. D. 1982; Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature, London 298:347–350
    [Google Scholar]
  35. Vernon S. K., Murthy S., Wilhelm J., Chanda P. K., Kalyan N., Lee S.-G., Hung P. P. 1991; Ultrastructural characterization of human immunodeficiency virus type 1 gag-containing particles assembled in a recombinant adenovirus vector system. Journal of General Virology 72:1243–1251
    [Google Scholar]
  36. Wilson-Rawls J., Saha S. K., Krajcsi P., Tollefson A. E., Gooding L. R., Wold W. S. M. 1990; A 6700 MW membrane protein is encoded by region E3 of adenovirus type 2. Virology 178:204–212
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-74-12-2819
Loading
/content/journal/jgv/10.1099/0022-1317-74-12-2819
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error